ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Feltquate David
ITeos Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BVF Partners L.P.(6.4%),BVF Inc.(6.4%), etc.
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gall Matthew
ITeos Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Aaron I. Davis(2.8%),Boxer Capital Management, LLC(2.6%)
ITeos Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Aaron I. Davis(2.8%),Boxer Capital Management, LLC(2.6%)
ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(4.4%),Oleg Nodelman(4.4%), etc.
ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.6%)
ITeos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.6%)
ITeos Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Aaron I. Davis(8.1%),Boxer Capital Management, LLC(7.9%), etc.
ITeos Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Boxer Asset Management Inc.(0%),Joe Lewis(0%)
ITeos Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Tang Capital Management, LLC(6.6%),Kevin Tang(6.6%), etc.
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Detheux Michel
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Feltquate David
ITeos Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Feltquate David
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Van Hauwermeiren Timothy
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ho Tony W
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee David K
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Davis Aaron I.
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hallal David
ITeos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DeSimone Jill